{
    "2021-07-20": [
        [
            {
                "time": "",
                "original_text": "乐普医疗收购博思美引深交所关注 要求释清合理性 关注函",
                "features": {
                    "keywords": [
                        "乐普医疗",
                        "收购",
                        "博思美",
                        "深交所",
                        "关注函",
                        "合理性"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "A股头条之上市公司（7.21）",
                "features": {
                    "keywords": [
                        "A股",
                        "上市公司"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "乐普医疗拟控股博思美收关注函 深交所：购买亏损资产是否有必要？ 关注函",
                "features": {
                    "keywords": [
                        "乐普医疗",
                        "控股",
                        "博思美",
                        "深交所",
                        "关注函",
                        "亏损资产"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "新冠集采双压下，乐普医疗挤进口腔、医美等暴利赛道！",
                "features": {
                    "keywords": [
                        "新冠",
                        "集采",
                        "乐普医疗",
                        "口腔",
                        "医美",
                        "暴利赛道"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "生物科技",
                        "医美"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "乐普医疗收关注函：补充说明实施此次交易、收购亏损公司的必要性和合理性 关注函",
                "features": {
                    "keywords": [
                        "乐普医疗",
                        "关注函",
                        "补充说明",
                        "交易",
                        "收购",
                        "亏损公司",
                        "必要性",
                        "合理性"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "深交所向乐普医疗下发关注函：补充说明实施此次交易、收购亏损公司的必要性和合理性 关注函",
                "features": {
                    "keywords": [
                        "深交所",
                        "乐普医疗",
                        "关注函",
                        "补充说明",
                        "交易",
                        "收购",
                        "亏损公司",
                        "必要性",
                        "合理性"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}